Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: Fact or artifact?

International Journal of Cancer

Volumn 124, Issue 9, 2009, Pages 2231-2235

  Goodman, Marc T ^a   Shvetsov, Yurii B ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Epidemiology; Incidence; Peritoneal cancer

Indexed keywords

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER STAGING; CONTROLLED STUDY; ELDERLY CARE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPILLARY CARCINOMA; PAPILLARY SEROUS CARCINOMA OF THE PERITONEUM; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; ADOLESCENT; ADULT; CANCER INVASION; CANCER REGISTRY; CHILD; CYSTADENOCARCINOMA; ETHNIC GROUP; INCIDENCE; INFANT; MIDDLE AGED; MORTALITY; NEWBORN; PERITONEUM TUMOR; PRESCHOOL CHILD; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYSTADENOCARCINOMA, PAPILLARY; CYSTADENOCARCINOMA, SEROUS; ETHNIC GROUPS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; MORTALITY; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; YOUNG ADULT;

EID: 63449118770     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24184     Document Type: Article

References (32)

1. Swerdlow M. Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary: case report. Am J Obstet Gynecol 1959;77:197-209.
2. Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D. Primary peritoneal serous papillary carcinoma: a new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer. Int J Gynecol Cancer 2001;11:403-408
3. Bloss JD, Brady MF, Liao SY, Rocereto T, Partridge EE, Clarke-Pearson DL; Gynecologic Oncology Group Study. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma. Gynecol Oncol 2003;89:148-154
4. Barda G, Menczer J, Chetrit A, Lubin F, Beck D, Piura B, Glezerman M, Modan B, Sadetzki S; National Israel Ovarian Cancer Group. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study. Am J Obstet Gynecol 2004;190:1039-1045
5. Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, Bloss LP, DiSaia PJ. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol 1993;50:347-351
6. Chen LM, Yamada SD, Fu YS, Baldwin RL, Karlan BY. Molecular similarities between primary peritoneal and primary ovarian carcinomas. Int J Gynecol Cancer 2003;13:749-755
7. Kurman RJ, Shih IeM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 2008;27:151-160
8. Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP. Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 2008;53:127-138
9. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG, et al. Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship. Am J Surg Pathol 2007;31:161-169
10. Roffers SD, Wu XC, Johnson CH, Correa CN. Incidence of extraovarian primary cancers in the United States, 1992-1997. Cancer 2003;97(Suppl 10):2643-2647
11. Menczer J, Chetrit A, Barda G, Lubin F, Fishler Y, Altaras M, Levavi H, Struewing JP, Sadetzki S, Modan B. Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 2003;88:58-61.
12. Bandera CA, Muto MG, Schorge JO, Berkowitz RS, Rubin SC, Mok SC. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol 1998;92:596-600.
13. Zeig-Owens R, Knowlton R, Gershman ST, Howe HL. CINA highlights of cancer incidence and mortality in the United States and Canada, 2000-2004. Springfield, IL: North American Association of Central Cancer Registries, 2007.
14. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of disease for oncology, 3rd edn. Geneva, Switzerland: World Health Organization, 2000.
15. Shambaugh EM, Weiss MA, eds. Summary staging guide (SSS1977). Cancer Surveillance Epidemiology and End Results Reporting, SEER Program. Bethesda, MD: NIH (Pub. No. 01-2313), 2001.
16. Young JL Jr, Roffers SD, Reis LAG, Fritz AG, Hurlbut AA, eds. SEER summary staging manual - 2000 codes and coding instructions (SSS2000). Bethesda, MD: National Cancer Institute, NIH (Pub. No. 01-4969), 2001.
17. US Census Bureau. United States Census 2000. Available at: http://www.census.gov/population/www/. Updated July 2008.
18. Surveillance Research Program, National Cancer Institute. SEER*Stat software, version 6.4.4. Bethesda, MD: National Cancer Institute, 2008. Available at: www.seer.cancer.gov/seerstat.
19. Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997;16:791-801.
20. Fay MP. Approximate confidence intervals for rate ratios from directly standardized rates with sparse data. Commun Stat Theor Meth 1999;28:2141-2160
21. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics 2006;62:847-854
22. Goodman MT, Howe HL, Tung KH, Hotes J, Miller BA, Coughlin SS, Chen VW. Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997. Cancer 2003;97(Suppl 10):2676-2685
23. Muto MG, Welch WR, Mok SC, Bandera CA, Fishbaugh PM, Tsao SW, Lau CC, Goodman HM, Knapp RC, Berkowitz RS. Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum. Cancer Res 1995;55:490-492
24. Schorge JO, Muto MG, Welch WR, Bandera CA, Rubin SC, Bell DA, Berkowitz RS, Mok SC. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst 1998;90:841-845
25. Huang LW, Garrett AP, Schorge JO, Muto MG, Bell DA, Welch WR, Berkowitz RS, Mok SC. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum. Am J Clin Pathol 2000;114:93-99
26. Dalrymple JC, Bannatyne P, Russell P, Solomon HJ, Tattersall MH, Atkinson K, Carter J, Duval P, Elliott P, Friedlander M, Murray J, Coppleson M. Extraovarian peritoneal serous papillary carcinoma: a clinicopathologic study of 31 cases. Cancer 1989;64:110-115
27. Fromm GL, Gershenson DM, Silva EG. Papillary serous carcinoma of the peritoneum. Obstet Gynecol 1990;75:89-95.
28. Killackey MA, Davis AR. Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma. Gynecol Oncol 1993;51:171-174
29. Choi CH, Kim TJ, Kim WY, Ahn GH, Lee JW, Kim BG, Lee JH, Bae DS. Papillary serous carcinoma in ovaries of normal size: a clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma. Gynecol Oncol 2007;105:762-768
30. Eltabbakh GH, Piver MS, Natarajan N, Mettlin CJ. Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer. Obstet Gynecol 1998;91:254-259
31. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW, Crum CP. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006;30:230-236
32. Goodman MT, Correa CN, Tung KH, Roffers SD, Cheng Wu X, Young JL Jr, Wilkens LR, Carney ME, Howe HL. Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 2003;97:2648-2659